Novavax (NVAX) Misses Q1 EPS by 1c
Tweet
Share
E-mail
Get Alerts NVAX Hot Sheet
Price: $3.88 -0.26%
Revenue Growth %: +85.7%
Financial Fact:
Net loss: -66.25M
Today's EPS Names:
MAXN, CSTR, ACU, More
Revenue Growth %: +85.7%
Financial Fact:
Net loss: -66.25M
Today's EPS Names:
MAXN, CSTR, ACU, More
Join SI Premium – FREE
Novavax (NASDAQ: NVAX) reported Q1 EPS of ($0.14), $0.01 worse than the analyst estimate of ($0.13). Revenue for the quarter came in at $9.7 million versus the consensus estimate of $9.33 million.
For earnings history and earnings-related data on Novavax (NVAX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Schlumberger (SLB) earnings in-line, revenue beats expectations
- Fifth Third Bancorp (FITB) Tops Q1 EPS by 2c
- American Express (AXP) down despite beating Q1 estimates on top and bottom lines
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
